Pages that link to "Q38323856"

The following pages link to Histone deacetylase 3 inhibits expression of PUMA in gastric cancer cells (Q38323856):

Displaying 19 items.

• Discovery of the first N-hydroxycinnamamide-based histone deacetylase 1/3 dual inhibitors with potent oral antitumor activity (Q33649465) (← links)
• Decreased expression of histone deacetylase 10 predicts poor prognosis of gastric cancer patients. (Q34371426) (← links)
• YY1-MIR372-SQSTM1 regulatory axis in autophagy (Q34373008) (← links)
• Regulation of CRADD-caspase 2 cascade by histone deacetylase 1 in gastric cancer (Q34420590) (← links)
• Ginsenoside Rg3 inhibits melanoma cell proliferation through down-regulation of histone deacetylase 3 (HDAC3) and increase of p53 acetylation (Q34734168) (← links)
• Histone deacetylase 3 inhibits new tumor suppressor gene DTWD1 in gastric cancer (Q35402636) (← links)
• Histone deacetylase 10 suppresses proliferation and invasion by inhibiting the phosphorylation of β-catenin and serves as an independent prognostic factor for human clear cell renal cell carcinoma. (Q35643696) (← links)
• Antitumor activity of the multikinase inhibitor regorafenib in patient-derived xenograft models of gastric cancer (Q36223964) (← links)
• Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies (Q36301520) (← links)
• Histone Deacetylase-3/CAGE Axis Targets EGFR Signaling and Regulates the Response to Anti-Cancer Drugs (Q36693836) (← links)
• Transcriptional regulation of E-cadherin and oncoprotein E7 by valproic acid in HPV positive cell lines (Q37110658) (← links)
• Histone deacetylase inhibitors restore toxic BH3 domain protein expression in anoikis-resistant mammary and brain cancer stem cells, thereby enhancing the response to anti-ERBB1/ERBB2 therapy (Q37589245) (← links)
• Histone deacetylase inhibitors and cell death (Q38217666) (← links)
• HDACs and HDAC Inhibitors in Cancer Development and Therapy (Q38947405) (← links)
• Downregulation of histone deacetylase 1 by microRNA-520h contributes to the chemotherapeutic effect of doxorubicin (Q39046067) (← links)
• Role of HDAC3-miRNA-CAGE Network in Anti-Cancer Drug-Resistance (Q60935566) (← links)
• Role of Histone Deacetylases in Carcinogenesis: Potential Role in Cholangiocarcinoma (Q90632680) (← links)
• p53 at the Crossroads between Different Types of HDAC Inhibitor-Mediated Cancer Cell Death (Q92083193) (← links)
• Epigenetic Regulation of TRAIL Signaling: Implication for Cancer Therapy (Q93082245) (← links)